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The 6 opioid receptor has been purified, in an active form, by succinylmorphine affinity chromatography. The receptor was purified partially from 
bovine frontal cortex and to apparent homogeneity from neuroblastoma x glioma hybrid NG108-15 cells as observed by sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis followed by silver staining. Antiserum to the purified bovine receptor inhibited ligand binding to membranes 
and immunoprecipitated a 58 kDa protein from NGl08-15 cells. Reconstitution of the receptor with lipids enhanced binding by 9-fold. The 58 
kDa band protein after electroelution and r~onstitution with lipids also showed specific binding, indicating that the receptor could be renatured 
even after SDS-PAGE in an appropriate lipid environm~t. 
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1. INTRODUCTION 
Opioid receptors are classified into p, 6 and K types 
based on ligand specificity and tissue distribution. How- 
ever, the molecular basis of this receptor heterogeneity 
still remains unclear. The frontal cortex of bovine brain 
is relatively enriched in delta receptors [I]. The neuro- 
blastoma x glioma hybrid NG108-15 cells express exclu- 
sively the 6 receptors on their cell surface [2,3]. Attempts 
to purify the p ]4,5] and K receptor [6,7] have been 
reported. There is also a report on the purification of 
the 6 opioid receptor [8] but in an inactive form. Re- 
cently, the delta opioid receptor has been cloned [9, lo]. 
In this report, we describe purification and reconstitu- 
tion of the functionally active 6 opioid receptor from the 
bovine frontal cortex and NG108-15 cells. 
2. MATERIALS AND METHODS 
2.1. Cell growth 
Neuroblastoma x glioma hybrid NG108-15 cells were grown as 
previously described [ll] in 162 cm* tissue culture flasks. C6 cells were 
grown in Dulbecco’s modified Eagle’s medium (G&co, USA) supple- 
mented with 10% fetal calf serum (Biological Industries, Israel), strep- 
tomycin (100 &ml) and ~ni~llin (100 unit~ml) in 75 cm’ flasks. 
2.2. Affinity purification 
Membranes were prepared from frontal cortex and NG108-15 cells 
*Corresponding author. Fax: (91) (11) 686-2663. 
Abbrev~tions~ CHAPS, 3-[(3~holamidopropyl) dimethyl ammonioll- 
pro ane-sulfonate; DADLE, D-Ala’, n-LeuS-enkephalin; DPDPE, 
D- en ,o-Pen’-enkephalin; ELISA, enzyme-linked immunosorbent l+- 
assay; IMS, immune mouse serum; Kd, equilibrium dissociation con- 
stant: kDa, kilodaltons; PIMS, pre-immune mouse serum; PMSF, 
phenyl methyl sulfonyl fluoride; SDS-PAGE, sodium dodecyl sulfate- 
polyac~lamide gel electrophoresis; WGA, wheat germ agglutinin. 
as described by Simonds et al. [12]. Membranes were washed by 
incubating in 50 mM T&I-ICI, pH 7.5, containing 1 mM PMSF 
(Sigma, USA) for 30 min at 37°C and solubilized using 10 mM 
CHAPS (Sigma, USA) as described by Simonds et al. [12] with minor 
modifications as described by Zukin and Maneckjee [13]. 6Succinyl- 
morphine was synthesized from morphine (Govt. Opium and Alkaloid 
Works, India) and coupled to Sepharose 4B (Pha~a~a, Sweden) 
using an ethylen~i~ine spacer arm [14]. CHAPS solubilized extract 
was diluted to 1 mM CHAPS and applied to the succinylmorphine- 
Sepharose column (1.2 x 13 cm) equilibrated with 50 mM Tris-HCl, 
pH 7.5, containing 1 mM CHAPS and 0.1 mM PMSF. The column 
was washed with 250 ml of the buffer and eluted with 100 ml of KC1 
(1 M) in the same buffer. Protein was monitored at 280 nm, the peak 
fractions pooled, dialysed and concentrated. 
2.3. Opioid binding 
Binding to membranes (750 pg) was carried out by incubating in 50 
mM Tris-HCl, pH 7.5, with [‘HIDADLE (New England Nuclear, 
USA; 30 Ci/mmol) for 60 min at 37’C in a final volume of 300 ~1. 
Non-specific binding determined in the presence of DADLE (National 
Institute on Drug Abuse, USA), 10 pM was 25-30% of total binding. 
Incubation was terminated by rapid filtration through Whatman GFI 
B filters. Filters were washed with 3 x 5 ml of ice-cold buffer, dried 
and the radioactivity determined in a toluene based scintillation fluid. 
CHAPS solubilized protein was precipitated using polyethylene gly 
co1 6000, centrifuged at 40,000 x g for 30 min and t3H]DADLE bind- 
ing to the pellet was studied in the presence of CHAPS, 1 mM as 
described by Chow and Zukin [IS] in a final volume of 300@. Binding 
to the affinity purified receptor (1.5 pug) was determined in the presence 
of CHAPS, 1 mM by incubating with PH]DADLE or rH]DPDPE 
(Amersham, UK) in a final volume of 500 ~1 for 60 min at 37’C. 
Non-specific binding was determined in the presence of 10 PM of the 
respective unlabelled ligand and was 20-25% of total binding. After 
cooling on ice, 50 ,& of ice-cold 1% y-globulin was added and the 
mixture applied to Sephadex G-25M column (9.1 ml bed volume, 
Pharmacia PDlO) equilibrated with Tris-HCl buffer containing 1 mM 
CHAPS. Initial 4.5 ml eluate was collected, mixed with 12 ml of Triton 
X-lO&toluene scintillation fluid and the radioactivity determined. 
2.4. Production of antiserum 
Four BALB/c mice were bled, serum prepared, pooled and stored 
as pre-immune mouse serum (PIMS). The mice were then immunized 
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with affinity-purified receptor preparation (20& from bovine frontal 
cortex emulsified in Freunds adjuvant, subcutaneously at fortnightly 
intervals. The mice were bled after four injections, the sera pooled and 
stored as immunized mouse serum (IMS). 
2.5. Immunoprecipitation 
Surface proteins of NG108-15 cells were labelled with “‘1 (Bhabha 
Atomic Research Centre, India) [16] and solubilized as described 
above. 1 ml of the diluted extract (CHAPS concentration 1 mM) was 
mixed with 200 ~1 of serum (diluted 150) at 4°C overnight. 100 ~1 of 
goat anti-mouse IgG + IgM conjugated to microspheres (Kirkegaard 
and Perry Lab., USA) was added and mixed at room temperature for 
2 h. The antigen-antibody complexes were collected by centrifugation. 
The microspheres were washed with 3 x 1 ml of phosphate-buffered 
saline containing 1% bovine serum albumin and treated with SDS- 
PAGE sample buffer. 
2.6. SDS-PAGE and electroelution 
Electrophoresis was carried out by the method of Laemmli [17] as 
modified by Ogita and Market? [18]. Gels were stained with silver by 
the method of Morrisey [19]. Protein was electroeluted [20] from gel 
slices by sealing in dialysis bags with 500 ~1 of Laemmli electrode 
buffer and placing the bags in a horizontal electrophoretic hamber. 
The tank was then filled with buffer and elution carried out at 20 mA 
for 5 h at room temperature. SDS was dialysed out and the protein 
concentrated by lyophilization. 
2.7. WGA-Sepharose chromatography 
Affinity purified receptor (400 pg) was applied on a WGA-Sepha- 
rose column (bed volume 10 ml) equilibrated with 50 mM Tris-HCl, 
pH 7.5, containing 1 mM CHAPS and 0.1 mM PMSF. The column 
was washed with 100 ml of buffer and eluted with 50 ml of 0.5 M 
N-acetyl n-glucosamine. The protein peaks were pooled, dialysed and 
concentrated. 
2.8. ELISA methods 
ELISA was carried out as decribed by Sharma et al. [21]. Wells of 
the ELISA plate were coated with cells/protein in 50 mM Tris-HCl, 
pH 7.5, by incubating at 37°C for 4 h. Non-specific sites were blocked 
with 3% bovine serum albumin. PIMS or IMS diluted 1:lOO was added 
and incubation carried out for 2 h at room temperature. The plates 
were washed thrice with phosphate-buffered saline, pH 7.2, and incu- 
bated with goat anti-mouse IgG + IgM coupled to peroxidase for 1 
h at room temperature. Colour was developed using orthophenylene 
diamine (0.5 mg/ml in 0.15 M citrate-phosphate buffer, pH 5.0) and 
H,02 (0.03%) and terminated after 10 min by 5 N H,SO,. 
2.9. Reconstitution into lipid vesicles 
Total lipids were extracted from bovine brain [22]. The extract was 
dissolved in chloroform, dried and resuspended in 50 mM Tris-HCl, 
pH 7.5. Vesicles were prepared and receptor reconstituted by the 
method of Scheideler and Zukin [23]. Lipid vesicles were prepared by 
direct probe sonication (Heat Systems-Ultrasonics Inc., USA). One 
second pulses of 80-100 W were given for 10 min and titanium shed 
by the probe was removed by centrifugation at 1000 x g for 10 min. 
Aftlnity-purified receptor in 50 mM Tris-HCl, pH 7.5, containing 10 
mM CHAPS was added to the suspension of lipid vesicles (pro- 
tein:lipid, 1:5), mixed and left for 1 h at 40°C. CHAPS was then diluted 
to a concentration of 1 mM and the vesicles collected by centrifugation 
at 100,000 x g for 5 h. Binding to the lipid vesicles was studied as 
described for the affinity-purified receptor. 
2.10. Protein estimation 
Protein was estimated in the membrane preparation by the method 
of Lowry [24] and in the CHAPS solubilized extract and affinity- 
purified receptor by the modified Bradford microassay [25]. 
3. RESULTS 
Affinity chromatography of the CHAPS solubilized 
protein from bovine frontal cortex on the succinylmor- 
phine-Sepharose column yielded a single peak which 
corresponded to about 0.5% of the protein in the mem- 
brane preparation. The peak showed significant 
DADLE binding activity (689 fmol/mg protein). In the 
case of NG108-15 cells too a single protein peak was 
eluted from the affinity column which corresponded to 
0.28% of the membrane protein. The peak showed sig- 
nificant binding to DADLE and had a specific activity 
of 1170 fmoYmg protein. In terms of binding, the yield 
was 11% from frontal cortex and 3% from NG108-15 
cells. Affinity chromatography performed with more 
than 10 preparations of bovine frontal cortex mem- 
branes and six different preparations of NG108-15 cells 
gave similar values. Parameters obtained from the satu- 
ration curves for the binding of [3H]DADLE at l-20 
nM are reported in Table I. [3H]DADLE was found to 
bind to a single class of binding sites (as shown by 
Scatchard plots). Though the affinities of DADLE for 
the membranes and the affinity-purified receptor were 
of the same order of magnitude, a significant increase 
in K,, was observed both in the case of frontal cortex and 
NG108-15 cells. 
In order to determine the purity of the affinity eluate, 
the purified protein from frontal cortex and NG108-15 
cells was analyzed by SDS-PAGE. Fig. 1 shows the 
pattern obtained in the case of the purified receptor 
from frontal cortex. Two bands, one of 58 kDa and the 
other of 30 kDa were seen. The affinity-purified protein 
from NG108-15 cells, however, showed a single band of 
58 kDa on SDS-PAGE followed by silver staining (Fig. 
2, lane 1). Since the opioid receptor is known to be a 
WGA binding glycoprotein, the affinity purified recep- 
tor from NG108-15 cells was further subjected to 
WGA-Sepharose chromatography. The receptor bound 
Table I 
Parameter estimates of [HIDADLE binding to receptors from bovine 
frontal cortex and NG108-15 cells 
& (nM) B max Hill 
(fmol/mg coefficient 
protein) 
Frontal cortex 
Membranes 
CHAPS extract 
Affinity-purified receptor 
NG108-15 cells 
Membranes 
CHAPS extract 
Affinity-purified receptor 
2.9 37 0.9 
3.8 40 1.0 
5.3 1,600 1.0 
2.8 162 0.9 
4.0 180 1.0 
9.5 3,640 1.0 
Values shown represent means of three experiments performed in 
duplicate for frontal cortex and two experiments performed in dupli- 
cate for the NG108-15 cells. Standard error was less than 10% in case 
of the membranes and CHAPS extract and less than 15% for the 
affinity purified protein. 
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Fig. 1. Analysis of affinity-purified receptor from bovine frontal cor- 
tex by SDS-PAGE on 7.5% gels. The gels were stained with silver. 
(Lanes 1 and 2) 25 and 5 pg of the affinity-purified receptor. 
to WGA and could be eluted with the competing sugar, 
N-acetyl-n-glucosamine. The WGA eluate showed a 
single band of 58 kDa (Fig. 2, lane 2) and retained the 
capacity to bind [3H]DADLE (data not shown). 
Since lipids are known to be required for optimal 
ligand binding to opioid receptors, reconstitution of the 
affinity-purified receptor was carried out in lipid vesi- 
cles prepared from bovine brain lipid extract. Reconsti- 
tution of the affinity-purified receptor from NGlOS-15 
cells into lipid vesicles resulted in a 9-fold enhancement 
of [3H]DADLE binding (Table II) suggesting that mem- 
brane lipid environment is important for ligand binding 
to the delta receptor. The 58 kDa band seen on SDS- 
PAGE was electroeluted (recovery was 48%) and recon- 
stituted into lipid vesicles. Significant [3H]DADLE 
binding was observed after reconstitution into lipid ves- 
58KDa- 
Fig. 2. Analysis of the receptor from NGlOS-15 cells by SDS-PAGE 
on 10% gels. Lanes 1 and 2 were stained with silver. (Lane 1) 5 pg of 
affinity purified receptor; (lane 2) 5 pug of WGA-Sepharose eluted 
receptor; (lane 3) autoradiographic pattern of ‘251-labelled antigen 
immunoprecipitated by IMS from NGlO&15 cells. 
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icles confirming the 58 kDa protein to be the 6 opioid 
receptor. 
Reactivity by ELISA of the antiserum raised to the 
affinity-purified receptor from frontal cortex is shown 
in Fig. 3. Strong cross-reactivity was seen with NG108- 
15 cells while no reactivity was seen with C6 glioma cells 
which lack opioid receptors. [3H]DADLE binding to 
both frontal cortex and NG108-15 cell membrane prep- 
aration could be inhibited by the antiserum raised (Fig. 
4). At a 1:lOO dilution, IMS inhibited [3H]DADLE 
binding to frontal cortex membrane preparation by 63% 
and to NG108-15 cell membrane preparation by 44% 
(Fig. 4). At 1: 10 dilution of serum, a non-specific inhibi- 
tion of 30% was observed even with PIMS. 
In an attempt o immunoprecipitate the antigen, sur- 
face proteins of NG108-15 cells were labelled with lz51, 
membranes prepared and solubilized using 10 mM 
CHAPS. The antigen was precipitated by incubating the 
extract (diluted 1:lO) with the serum and collecting the 
antigen-antibody complexes on goat anti-mouse 
IgG + IgM coupled to microspheres. On SDS-PAGE 
and autoradiography, a single band was seen (Fig. 2, 
lane 3) which co-migrated with the affinity purified re- 
ceptor and had a molecular weight of 58 kDa. Incuba- 
tion with PIMS did not show any band (data not 
shown). Immunoprecipitation studies were also carried 
out with unlabelled NG108-15 cells. [3H]DADLE bind- 
ing to the supernatant, after immunoprecipitation of the 
antigen, was studied to look for residual binding sites. 
44 fmol of [3H]DADLE were bound per mg protein in 
case of IMS and 74 fmol in the case of PIMS. This 
corresponded to a 41% decrease in binding after precip- 
itation with IMS compared to PIMS (data not shown). 
Table II 
[‘HIDADLE and [‘HIDPDPE binding to the affinity-purified receptor 
from NG108-15 cells 
Specific binding (fmol/mg protein) 
Affinity-purified receptor 
Affinity-purified receptor 
reconstituted in lipid vesicles 
58 kDa band protein* 
reconstituted in lipid vesicles 
[‘HIDADLE [‘HIDPDPE 
1,187 2,226 
10,304 ND 
4,360 ND 
[‘HIDADLE and [‘HIDPDPE, 5 nM were used to study binding to 
affinity-purified receptor or affinity-purified receptor reconstituted 
into lipid vesicles (26 fig) as described in section 2. 
*SDS-PAGE of the affinity-purified receptor was carried out on 10% 
gels. A lane was cut out and stained with silver. Gel from another lane 
corresponding to the 58 kDa band was excised, the protein electro- 
eluted and reconstituted in lipid vesicles. Binding of [3H]DADLE was 
carried out as described in section 2. Control lipid vesicles without 
protein did not show any specific binding. Non-specific binding was 
determined in the presence of DADLE, 10 pm and was 20-30% of 
total binding. Values shown are averages from two experiments per- 
formed in duplicate. ND = not done. 
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conversion of the receptors into a low affinity state [26]. 
Reconstitution of the purified~ receptor with Gi protein 
has been reported by Ueda et al. [271 to increase agonist 
binding to the receptor by 215-fold. 
In this study, reconstitution of the purified receptor 
into lipid vesicles resulted in enhanced [3H]DADLE 
binding suggesting that membrane lipid environment 
plays a major role in maintaining the S receptor in an 
active state. Similar observations have been made with 
both the ,u [28] and the x: [7] receptors. 
Fig. 3. Reactivity by ELISA of immunized mouse serum (IMS) and 
pre-immune mouse serum (PIMS). Frontal cortex membranes (FC), 
100 pg; NG108-15 cells (NG), 1 x 10’; C6 glioma cells (C6), 1 x 10’; 
or affinity-purified receptor from frontal cortex (AP), 15 pg was 
coated per well of the ELISA plate and ELISA performed as described 
in section 2. Values shown are mean f S.E.M. from 3 experiments 
performed in triplicate. 
4. DISCUSSION 
We describe purification in an active form of the 6 
opioid receptor from the bovine frontal cortex and 
NG10815 cells. The receptor has been purified to ap- 
parent homogeneity as seen on SDS-PAGE followed by 
silver staining from the NG108-15 cells and partially 
from the bovine frontal cortex. The affinity purified 
receptor bound both [3H]DADLE and [3H]DPDPE spe- 
cifically though with much lower specific activity than 
expected. This could be explained by the loss of the 
guanyl nucleotide binding protein (G-protein) during 
purification since no effect of guanyl nucleotides could 
be seen on [3H]DADLE binding to the affinity-purified 
receptor (data not shown) nor bands in the molecular 
weight range of 4&43 kDa (molecular weight of G- 
proteins) observed on SDS-PAGE. G-proteins are 
known to be important for high affinity agonist binding 
to the receptor and complete uncoupling results in the 
Fig. 4. Inhibition of [‘HIDADLE specific binding to frontal cortex 
membranes o,o) and to NG108-15 cells (A,A) by immunized mouse 
serum (O-O, A-A) and pre-immune mouse serum (+o, A-A). Frontal 
cortex/NG108-15 cell membranes (75Opg) were incubated with differ- 
ent dilutions of the sera (100/l) for 1 hat 37°C. [‘HIDADLE (1 .O nM) 
was then added and incubation carried out further for 1 h at 37°C. 
Non-specific binding was determined in the presence of DADLE, 10 
PM and was 25-308 of total binding. Rest of the assay details are as 
given in section 2 for membranes. Each point shown represents mean 
of values from 3 experiments performed in duplicate. Standard error 
was less than 10%. 
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The 58 kDa band protein observed on SDS-PAGE 
when electroeluted and reconstituted into lipid vesicles 
retained the capacity to bind [3H]DADLE. These obser- 
vations confirmed that the 58 kDa protein was the re- 
ceptor. Simonds et al. [8] have by convalent labelling 
with 3-methylfentanyl isothiocyanate obtained a molec- 
ular weight of 58 kDa for the 6 receptor. The 6 receptor 
purified by us also had a molecular weight of 58 kDa 
which agrees well with that reported by them. Our study 
is the first report on the reconstitution and renaturation 
of the 6 opioid receptor after SDS-PAGE. 
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